Methionine enkephalin(MENK) upregulated memory T cells in anti-influenza response
Open Access
- 12 October 2023
- journal article
- research article
- Published by Springer Nature in BMC Immunology
- Vol. 24 (1) , 1-11
Abstract
Novel prophylactic drugs and vaccination strategies for protection against influenza virus should induce specific effector T-cell immune responses in pulmonary airways and peripheral lymphoid organs. Designing approaches that promote T-cell-mediated responses and memory T-cell differentiation would strengthen host resistance to respiratory infectious diseases. The results of this study showed that pulmonary delivery of MENK via intranasal administration reduced viral titres, upregulated opioid receptor MOR and DOR, increased the proportions of T-cell subsets including CD8+ T cells, CD8+ TEM cells, NP/PA-effector CD8+ TEM cells in bronchoalveolar lavage fluid and lungs, and CD4+/CD8+ TCM cells in lymph nodes to protect mice against influenza viral challenge. Furthermore, we demonstrated that, on the 10th day of infection, the proportions of CD4+ TM and CD8+ TM cells were significantly increased, which meant that a stable TCM and TEM lineage was established in the early stage of influenza infection. Collectively, our data suggested that MENK administered intranasally, similar to the route of natural infection by influenza A virus, could exert antiviral activity through upregulating T-cell-mediated adaptive immune responses against influenza virus.Keywords
Funding Information
- the Doctoral Start-up Foundation of Liaoning Province and the National College Students Innovation and Entrepreneurship Training Program ((2020-BS-246 to JT ) and (201910160042 to JT ))
This publication has 41 references indexed in Scilit:
- The administration of oseltamivir results in reduced effector and memory CD8 + T cell responses to influenza and affects protective immunityThe FASEB Journal, 2014
- T cell mediated immunity to influenza: mechanisms of viral controlTrends in Immunology, 2014
- Methionine enkephalin (MENK) improves lymphocyte subpopulations in human peripheral blood of 50 cancer patients by inhibiting regulatory T cells (Tregs)Human Vaccines & Immunotherapeutics, 2014
- Immunotherapy of cancer via mediation of cytotoxic T lymphocytes by methionine enkephalin (MENK)Cancer Letters, 2014
- Influenza infection results in local expansion of memory CD8+ T cells with antigen non-specific phenotype and functionClinical and Experimental Immunology, 2013
- Inhibition of TGF-β1 Signaling Promotes Central Memory T Cell DifferentiationThe Journal of Immunology, 2013
- Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infectionJournal of General Virology, 2013
- The design and proof of concept for a CD8+ T cell‐based vaccine inducing cross‐subtype protection against influenza A virusImmunology & Cell Biology, 2012
- Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir ResistanceScience, 2010
- Early establishment of diverse T cell receptor profiles for influenza-specific CD8+CD62Lhimemory T cellsProceedings of the National Academy of Sciences, 2006